Vimarsana
Biggest News Aggregation in the World

Geoff Lopes News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Geoff Lopes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Geoff Lopes Today - Breaking & Trending Today

Total Economic Impact Study of the Celigo Integration Platform Finds a Return on Investment of 364% - Vimarsana News

Total Economic Impact Study of the Celigo Integration Platform Finds a Return on Investment of 364%

/PRNewswire/ -- Celigo, the leading integration-driven automation company, today released a commissioned study conducted by Forrester Consulting on The Total...

Total Economic Impact Study of the Celigo Integration Platform Finds a Return on Investment of 364% - Vimarsana News

Total Economic Impact Study of the Celigo Integration Platform Finds a Return on Investment of 364%

Recent Independent Study Reveals Celigo Provides Greater Customer, Partner and End User Experience through Process Efficiencies, Improved IT and B...

National Quality Initiatives Amplify Health Systems' Focus on Effective Glycemic Management as Glytec Fortifies Industry Leadership Position - Vimarsana News

National Quality Initiatives Amplify Health Systems' Focus on Effective Glycemic Management as Glytec Fortifies Industry Leadership Position

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
Glytec and Roche Announce Strategic Partnership to Bring Digital Health Innovation in Glycemic Decis - Vimarsana News

Glytec and Roche Announce Strategic Partnership to Bring Digital Health Innovation in Glycemic Decis

As CMS Creates an Emphasis on Hyperglycemia and Hypoglycemia Rates in the Hospital, Partnership Aims to Transform the Standard of CareWALTHAM, Mass.--(BUSINESS WIRE)--Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced a strategic partnership with Roche...